Quality of life after patient-initiated vs physician-initiated response to symptom monitoring: the SYMPRO-Lung trial

Author:

Billingy Nicole E1ORCID,Tromp Vashti N M F2ORCID,Aaronson Neil K3ORCID,Hoek Rianne J A1ORCID,Bogaard Harm Jan1ORCID,Onwuteaka-Philipsen Bregje D4ORCID,van de Poll-Franse Lonneke356ORCID,Hugtenburg Jacqueline G2ORCID,Belderbos José7ORCID,Becker-Commissaris Annemarie1ORCID,van den Hurk Corina J G5ORCID,Walraven Iris8,van Walree N C,de Jaeger K,Samii S,Lam-Wong W Y,Koppe F,Stigt J A,Herder G J M,Welling A,Schuurbiers-Siebers O C J,Smit J M,Staal-van den Brekel A J,de Jong W K,

Affiliation:

1. Department of Pulmonary Diseases, Cancer Center Amsterdam, Amsterdam Public Health Research Institute, Amsterdam University Medical Centers (UMC), Vrije Universiteit Amsterdam , Amsterdam, the Netherlands

2. Department of Clinical Pharmacology and Pharmacy, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam , Amsterdam, the Netherlands

3. Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute , Amsterdam, the Netherlands

4. Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam , the Netherlands

5. Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL) , Utrecht, the Netherlands

6. CoRPS—Center of Research on Psychological and Somatic Disorders, Department of Medical and Clinical Psychology, Tilburg University , Tilburg, the Netherlands

7. Department of Radiation Oncology, Netherlands Cancer Institute , Amsterdam, the Netherlands

8. Department for Health Evidence, Radboud University Medical Center , Nijmegen, the Netherlands

Abstract

Abstract Background Previous studies using patient-reported outcomes measures (PROMs) to monitor symptoms during and after (lung) cancer treatment used alerts that were sent to the health-care provider, although an approach in which patients receive alerts could be more clinically feasible. The primary aim of this study was to compare the effect of weekly PROM symptom monitoring via a reactive approach (patient receives alert) or active approach (health-care provider receives alert) with care as usual on health-related quality of life (HRQOL) at 15 weeks after start of treatment in lung cancer patients. Methods The SYMPRO–Lung trial is a multicenter randomized controlled trial using a stepped wedge design. Stage I-IV lung cancer patients in the reactive and active groups reported PROM symptoms weekly, which were linked to a common alerting algorithm. HRQOL was measured by the EORTC QLQ-C30 at baseline and after 15 weeks. Linear regression analyses and effect size estimates were used to assess mean QOL–C30 change scores between groups, accounting for confounding. Results A total of 515 patients were included (160 active group, 89 reactive group, 266 control group). No differences in HRQOL were observed between the reactive and active group (summary score: unstandardized beta [B] = 0.51, 95% confidence interval [CI] = -3.22 to 4.24, Cohen d effect size [ES] = 0.06; physical functioning: B = 0.25, 95% CI = -5.15 to 4.64, ES = 0.02). The combined intervention groups had statistically and clinically significantly better mean change scores on the summary score (B = 4.85, 95% CI = 1.96 to 7.73, ES = 0.57) and physical functioning (B = 7.00, 95% CI = 2.90 to 11.09, ES = 0.71) compared with the control group. Conclusions Weekly PRO symptom monitoring statistically and clinically significantly improves HRQOL in lung cancer patients. The logistically less intensive, reactive approach may be a better fit for implementation.

Funder

Zorg Innovatiefonds

Stichting Kwaliteitsgelden Medisch Specialisten

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3